Published online before print April 8, 2002, doi: 10.1161/01.CIR.0000015698.54752.6D
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:1887.)
© 2002 American Heart Association, Inc.
Brief Rapid Communications |
Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation
Early Clinical Experience
From the Cardiovascular Center Bethanien (H.S., T.T., D.F., U.K., D.S.), Frankfurt; Germany; University of California (M.D.L., T.N.), San Francisco; Appriva Medical (M.D., T.N.), Sunnyvale, Calif; the Department of Cardiology (H.O.), University Hospital Bonn, Bonn, Germany; Centro Cardiologico Monzino Istituto di Ricerca e Cura a Carattere Scientifico (A.B., P.D.B.), Milano, Italy; Swedish Medical Center (M.R.), Seattle, Wash; Hospital S Raffaele (C.D.), Milano, Italy; Emory University Hospital (P.B.), Atlanta, Ga; and St Luke’s Hospital (P.K.), Kansas City, Mo.
Correspondence to Horst Sievert, MD, Cardiovascular Center Bethanien, Im Prüfling 23, 60389 Frankfurt, Germany. E-mail horst.sievert@ dgn.de
Background— Thromboembolism due to atrial fibrillation (AF) is a frequent cause of stroke. More than 90% of thrombi in AF form in the left atrial appendage (LAA). Obliteration of the appendage may prevent embolic complications.
Methods and Results— We evaluated the feasibility and safety of implanting a novel device for percutaneous left atrial appendage transcatheter occlusion (PLAATO). LAA occlusion using the PLAATO system was attempted in 15 patients with chronic AF at high risk for stroke, who are poor candidates for long-term warfarin therapy. The implant consists of a self-expanding nitinol cage covered with a polymeric membrane (ePTFE). The LAA was successfully occluded in 15/15 patients (100%). Angiography and transesophageal echocardiography (TEE) during the procedure showed that the device was well-seated in all patients and that there was no evidence of perforation, device embolization, or interference with surrounding structures. In 1 patient, the first procedure was complicated by a hemopericardium, which occurred during LAA access. A second attempt 30 days later was successful with no untoward sequela. No other complications occurred. At 1-month follow-up, chest fluoroscopy and TEE revealed continued stable implant position with smooth atrial-facing surface and no evidence of thrombus.
Conclusions— Thus, transcatheter closure of the LAA is feasible in humans. This novel implant technology may be appropriate for patients with AF who are not suitable candidates for anticoagulation therapy. Further trials are needed to show the long-term safety and its efficacy in reducing stroke.
Key Words: atrial flutter • embolism • stroke • thrombus • atrium
This article has been cited by other articles:
 |
|
 |
|
  D. R. Holmes Jr and R. S. Schwartz Left Atrial Appendage Occlusion Eliminates the Need for Warfarin Circulation, November 10, 2009; 120(19): 1919 - 1926. [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Block, S. Burstein, P. N. Casale, P. H. Kramer, P. Teirstein, D. O. Williams, and M. Reisman Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy: 5-Year Results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study J. Am. Coll. Cardiol. Intv., July 1, 2009; 2(7): 594 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sievert and Y. L. Bayard Percutaneous Closure of the Left Atrial Appendage: A Major Step Forward J. Am. Coll. Cardiol. Intv., July 1, 2009; 2(7): 601 - 602. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fumoto, A. M. Gillinov, Y. Ootaki, M. Akiyama, D. Saeed, T. Horai, C. Ootaki, D. G. Vince, Z. B. Popovic, R. Dessoffy, et al. A novel device for left atrial appendage exclusion: the third-generation atrial exclusion device. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1019 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. L Bayard, S. H Ostermayer, and H. Sievert Alternatives to warfarin in atrial fibrillation: drugs and devices Heart, September 1, 2008; 94(9): 1113 - 1116. [Full Text] [PDF]
|
|
|
|
|
|
P Su, K P McCarthy, and S Y Ho Occluding the left atrial appendage: anatomical considerations Heart, September 1, 2008; 94(9): 1166 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Gillinov Advances in Surgical Treatment of Atrial Fibrillation Stroke, February 1, 2007; 38(2): 618 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Onalan and E. Crystal Left Atrial Appendage Exclusion for Stroke Prevention in Patients With Nonrheumatic Atrial Fibrillation Stroke, February 1, 2007; 38(2): 624 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kamohara, K. Fukamachi, Y. Ootaki, M. Akiyama, F. Cingoz, C. Ootaki, D. G. Vince, Z. B. Popovic, M. W. Kopcak Jr, R. Dessoffy, et al. Evaluation of a novel device for left atrial appendage exclusion: The second-generation atrial exclusion device. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 340 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Hylek, J. D'Antonio, C. Evans-Molina, C. Shea, L. E. Henault, and S. Regan Translating the Results of Randomized Trials into Clinical Practice: The Challenge of Warfarin Candidacy Among Hospitalized Elderly Patients With Atrial Fibrillation Stroke, April 1, 2006; 37(4): 1075 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. K. Mohrs, R. Schraeder, S. E. Petersen, D. Scherer, B. Nowak, H.-U. Kauczor, and T. Voigtlaender Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO): Planning and Follow-Up Using Contrast-Enhanced MRI Am. J. Roentgenol., February 1, 2006; 186(2): 361 - 364. [Full Text] [PDF]
|
|
|
|
|
|
K. Kamohara, K. Fukamachi, Y. Ootaki, M. Akiyama, F. Zahr, M. W. Kopcak Jr, R. Dessoffy, Z. B. Popovic, M. Daimon, D. M. Cosgrove, et al. A novel device for left atrial appendage exclusion J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1639 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Ostermayer, M. Reisman, P. H. Kramer, R. V. Matthews, W. A. Gray, P. C. Block, H. Omran, A. L. Bartorelli, P. Della Bella, C. Di Mario, et al. Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO System) to Prevent Stroke in High-Risk Patients With Non-Rheumatic Atrial Fibrillation: Results From the International Multi-Center Feasibility Trials J. Am. Coll. Cardiol., July 5, 2005; 46(1): 9 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Schneider, J. Finsterer, and C. Stollberger Effects of percutaneous left atrial appendage transcatheter occlusion (PLAATO) on left atrial structure and function J. Am. Coll. Cardiol., February 15, 2005; 45(4): 634 - 635. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Thijs More bad news about atrial fibrillation Eur. Heart J., October 1, 2004; 25(19): 1670 - 1671. [Full Text] [PDF]
|
|
|
|
|
|
I. R. Hanna, P. Kolm, R. Martin, M. Reisman, W. Gray, and P. C. Block Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): Six-month echocardiographic follow-up J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1868 - 1872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Quader, P. M. McCarthy, A. M. Gillinov, J. M. Alster, D. M. Cosgrove III, B. W. Lytle, and E. H. Blackstone Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann. Thorac. Surg., May 1, 2004; 77(5): 1514 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Kaufman and A. L. Waldo The impact of asymptomatic atrial fibrillation J. Am. Coll. Cardiol., January 7, 2004; 43(1): 53 - 54. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stollberger, B. Schneider, and J. Finsterer Elimination of the Left Atrial Appendage To Prevent Stroke or Embolism?: Anatomic, Physiologic, and Pathophysiologic Considerations Chest, December 1, 2003; 124(6): 2356 - 2362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W Troughton, C. R Asher, and A. L Klein The role of echocardiography in atrial fibrillation and cardioversion Heart, December 1, 2003; 89(12): 1447 - 1454. [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Singer A 60-Year-Old Woman With Atrial Fibrillation JAMA, October 22, 2003; 290(16): 2182 - 2189. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Blackshear, W. D. Johnson, J. A. Odell, V. S. Baker, M. Howard, L. Pearce, C. Stone, D. L. Packer, and H. V. Schaff Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1249 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. n. Garcia-Fernandez, E. Perez-David, J. Quiles, J. Peralta, I. Garcia-Rojas, J. Bermejo, M. Moreno, and J. Silva Role of left atrial appendageobliteration in stroke reductionin patients with mitral valve prosthesis: A transesophageal echocardiographic study J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1253 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Halperin and M. Gomberg-Maitland Obliteration of the leftatrial appendage forprevention of thromboembolism J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1259 - 1261. [Full Text] [PDF]
|
|
|
|
 |
|
 G.Q. Villani, M. Piepoli, P.E. Villani, and A. Capucci Anticoagulation in atrial fibrillation: what is certain and what is to come Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H45 - H50. [Abstract] [PDF]
|
|
|
|
|
|
C. Stollberger, B. Schneider, J. Finsterer, H. Sievert, T. Trepels, D. Fleschenberg, U. Krumsdorf, D. Scherer, M. D. Lesh, T. Nakai, et al. Is Percutaneous Left Atrial Appendage Transcatheter Occlusion an Alternative to Oral Anticoagulation in Patients With Atrial Fibrillation? * Response Circulation, January 7, 2003; 107 (1): e11 - e12. [Full Text] [PDF]
|
|
|
|
|
|
G. Bonanomi, M. A. Zenati, and D. Schwartzman Left atrial appendectomy and maze J. Am. Coll. Cardiol., January 1, 2003; 41(1): 170 - 170. [Full Text] [PDF]
|
|
|
|
 |
|
 Percutaneous Left Atrial Appendage Occlusion Journal Watch Cardiology, June 7, 2002; 2002(607): 4 - 4. [Full Text]
|
|